{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:24:48Z","timestamp":1772637888284,"version":"3.50.1"},"reference-count":45,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cH\u00f4pital Nord Franche-Comt\u00e9\u201d"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Arterial hypertension (AH) is a frequent comorbidity in patients with osteoarthritis (OA). Among antihypertensive agents, angiotensin-converting enzyme (ACE) inhibitors, calcium channel blockers (CCBs), angiotensin II receptor blockers (ARBs), and beta-blockers (\u03b2Bs) have been suggested to influence OA progression and symptomatology. The aim of this study was to assess whether the duration of effectiveness (DE) of viscosupplementation (VS) differs between patients with knee OA who are receiving antihypertensive treatment and those who are not. Methods: This post hoc analysis was conducted using data from a cross-sectional clinical trial (ClinicalTrials.gov Identifier: NCT04988698). The study included consecutive patients with knee OA who came for consultation at the Rheumatology Department and had received intra-articular hyaluronic acid injections within the past three years. The primary outcome was DE, self-reported by patients as the number of weeks of symptom relief. Associations between DE and various factors, including demographics, disease duration, radiographic OA severity (Kellgren\u2013Lawrence grade and affected compartments), comorbidities, OA treatment history, antihypertensive therapy, physical activity level, and prior VS sessions, were analyzed using bivariate and multivariate models. Results: A total of 105 patients (65 women, 149 treated knees) were included. The mean age was 66.1 \u00b1 13.2 years, and the mean body mass index (BMI) was 27.5 kg\/m2. Thirty-eight percent of patients were receiving antihypertensive treatment (mean number of agents: 1.9; range: 1\u20134), including CCBs (n = 15), ACE inhibitors (n = 13), ARBs (n = 7), \u03b2Bs (n = 6), and diuretics (n = 2). The overall mean DE of VS was 48.2 \u00b1 24.8 weeks, with a trend toward longer DE in hypertensive patients compared to non-hypertensive patients (53.1 \u00b1 31.3 vs. 45.4 \u00b1 19.8 weeks, p = 0.06). Bivariate analysis identified significantly longer DE in patients with BMI &lt; 27.5 kg\/m2 (p = 0.002), Kellgren\u2013Lawrence grade &lt; 4 (p = 0.008), an active lifestyle (p = 0.005), unicompartmental OA (p = 0.01), medial tibiofemoral joint space narrowing (p = 0.046), and fewer than four prior VS sessions (p = 0.02). In multivariate analysis, AH was strongly associated with prolonged DE (p &lt; 0.001), despite AH patients having a higher BMI (29.8 \u00b1 5.5 vs. 25.2 \u00b1 5.2 kg\/m2, p = 0.001) and being more frequently sedentary (25.5% vs. 13.8%, p = 0.07). A trend toward longer DE was observed in patients treated with \u03b2Bs and ARBs but not with CCBs or ACE inhibitors. Additional independent predictors of longer DE included BMI &lt; 27.5 kg\/m2 (p &lt; 0.001), unicompartmental OA (p = 0.02), fewer than four prior VS sessions (p = 0.02), and an active lifestyle (p = 0.027). Conclusions: These findings suggest that antihypertensive treatment may extend the effectiveness of viscosupplementation in knee OA. However, the sample size was insufficient to determine whether specific classes of antihypertensive agents provide greater benefits. Further large-scale, prospective studies are warranted to clarify the potential impact of antihypertensive medications on viscosupplementation outcomes in knee OA.<\/jats:p>","DOI":"10.3390\/jcm15051935","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:51:33Z","timestamp":1772614293000},"page":"1935","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Can Certain Antihypertensives Prolong the Efficacy of Hyaluronic Acid Injections in Patients with Osteoarthritis of the Knee? Post Hoc Analysis of a Prospective Observational Trial (PRESAGE)"],"prefix":"10.3390","volume":"15","author":[{"given":"Arthur","family":"Dollinger","sequence":"first","affiliation":[{"name":"Department of Rheumatology, H\u00f4pital Nord Franche-Comt\u00e9, 100 Route de Moval, CS 10490, Trevenans, 90015 Belfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3950-2410","authenticated-orcid":false,"given":"Thomas","family":"Lohse","sequence":"additional","affiliation":[{"name":"Department of Cardiology, H\u00f4pital de la Croix-Rousse, Hospices Civils de Lyon, 69004 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Dolci","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Soins Intensifs Cardiologiques (USIC), H\u00f4pital Cardiologique, 69500 Bron, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Rapp","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4pital Nord Franche-Comt\u00e9, 100 Route de Moval, CS 10490, Trevenans, 90015 Belfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Bourgoin","sequence":"additional","affiliation":[{"name":"Clinical Research and Innovation Unit, H\u00f4pital Nord Franche-Comt\u00e9, 90015 Belfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Lohse","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4pital Nord Franche-Comt\u00e9, 100 Route de Moval, CS 10490, Trevenans, 90015 Belfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0353-6292","authenticated-orcid":false,"given":"Thierry","family":"Conrozier","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4pital Nord Franche-Comt\u00e9, 100 Route de Moval, CS 10490, Trevenans, 90015 Belfort, France"},{"name":"Clinical Research and Innovation Unit, H\u00f4pital Nord Franche-Comt\u00e9, 90015 Belfort, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"ref_1","unstructured":"GBD 2021 Osteoarthritis Collaborators (2023). Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol., 5, e508\u2013e522."},{"key":"ref_2","first-page":"24","article-title":"Knee and hip osteoarthritis as predictors of premature death: A review of the evidence","volume":"37","author":"Cleveland","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jbspin.2020.09.004","article-title":"Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis","volume":"87","author":"Sellam","year":"2020","journal-title":"Jt. Bone Spine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","article-title":"An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)","volume":"44","author":"Cooper","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_6","first-page":"3","article-title":"Viscosupplementation: A new concept in the treatment of osteoarthritis","volume":"39","author":"Balazs","year":"1993","journal-title":"J. Rheumatol. Suppl."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/M14-1231","article-title":"Comparative Effectiveness of Pharmacologic Interventions for Knee Osteoarthritis","volume":"162","author":"Bannuru","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"351S","DOI":"10.1177\/1947603519888783","article-title":"Safety of Intra-Articular Hyaluronic Acid for Knee Osteoarthritis: Systematic Review and Meta-Analysis of Randomized Trials Involving More than 8,000 Patients","volume":"13","author":"Miller","year":"2021","journal-title":"Cartilage"},{"key":"ref_9","first-page":"1124","article-title":"The discrepancy between recommendations and clinical practice for viscosupplementation in osteoarthritis: Mind the gap!","volume":"19","author":"Migliore","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/art.41142","article-title":"2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee","volume":"72","author":"Kolasinski","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/jor.23529","article-title":"Obesity and radiological severity are associated with viscosupplementation failure in patients with knee osteoarthritis","volume":"35","author":"Eymard","year":"2017","journal-title":"J. Orthop. Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Rapp, C., Boudif, F., Bourgoin, C., Lohse, A., and Conrozier, T. (2024). A Cross-Sectional Study of Factors Predicting the Duration of the Efficacy of Viscosupplementation in Knee Osteoarthritis. J. Clin. Med., 13.","DOI":"10.20944\/preprints202402.1442.v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1136\/ard.2011.155119","article-title":"Defining radiographic incidence and progression of knee osteoarthritis: Suggested modifications of the Kellgren and Lawrence scale","volume":"70","author":"Felson","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Liu, Y., and Du, G. (2024). Blood pressure is associated with knee pain severity in middle-aged and elderly individuals with or at risks for osteoarthritis: Data from the Osteoarthritis Initiative. BMC Musculoskelet. Disord., 25.","DOI":"10.1186\/s12891-024-07657-x"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.joca.2022.11.014","article-title":"The effects of losartan or angiotensin II receptor antagonists on cartilage: A systematic review","volume":"31","author":"Yamaura","year":"2023","journal-title":"Osteoarthr. Cartil."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.peptides.2013.05.012","article-title":"Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis","volume":"46","author":"Silveira","year":"2013","journal-title":"Peptides"},{"key":"ref_18","first-page":"12584","article-title":"Captopril, an angiotensin-converting enzyme inhibitor, possesses chondroprotective efficacy in a rat model of osteoarthritis through suppression local renin-angiotensin system","volume":"8","author":"Tang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.intimp.2018.11.001","article-title":"The renin-angiotensin system in the synovium promotes periarticular osteopenia in a rat model of collagen-induced arthritis","volume":"65","author":"Wang","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/taap.2000.8985","article-title":"Effects of captopril on interleukin-6, leukotriene B(4), and oxidative stress markers in serum and inflammatory exudate of arthritic rats: Evidence of antiinflammatory activity","volume":"168","author":"Agha","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/jch.14362","article-title":"The effects of different antihypertensive drugs on pain and joint space width of knee osteoarthritis\u2014A comparative study with data from Osteoarthritis Initiative","volume":"23","author":"Li","year":"2021","journal-title":"J. Clin. Hypertens."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/acr.23091","article-title":"Association of Beta-Blocker Use With Less Prevalent Joint Pain and Lower Opioid Requirement in People With Osteoarthritis","volume":"69","author":"Valdes","year":"2017","journal-title":"Arthritis Care Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1093\/rheumatology\/keab234","article-title":"\u03b2-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: A propensity score-matched cohort study","volume":"60","author":"Nakafero","year":"2021","journal-title":"Rheumatology"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Du, K., Li, A., Zhang, C.Y., Li, S.M., and Chen, P. (2024). Repurposing antihypertensive drugs for pain disorders: A drug-target mendelian randomization study. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1448319"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joca.2019.08.008","article-title":"Lack of evidence that beta blocker use reduces knee pain, areas of joint pain, or analgesic use among individuals with symptomatic knee osteoarthritis","volume":"28","author":"Zhou","year":"2020","journal-title":"Osteoarthr. Cartil."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2174\/1389201020666190506124548","article-title":"Does Nimodipine, a Selective Calcium Channel Blocker, Impair Chondrocyte Proliferation or Damage Extracellular Matrix Structures?","volume":"20","author":"Kaplan","year":"2019","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1152\/ajpregu.1992.263.1.R70","article-title":"Diverse effects of calcium channel blockers on skeletal muscle glucose transport","volume":"263","author":"Cartee","year":"1992","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Uzieliene, I., Bernotiene, E., Rakauskiene, G., Denkovskij, J., Bagdonas, E., Mackiewicz, Z., Porvaneckas, N., Kvederas, G., and Mobasheri, A. (2019). The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00756"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"117292","DOI":"10.1016\/j.lfs.2020.117292","article-title":"Nifedipine inhibits oxidative stress and ameliorates osteoarthritis by activating the nuclear factor erythroid-2-related factor 2 pathway","volume":"253","author":"Yao","year":"2020","journal-title":"Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Aleksiuk, V., Baleisis, J., Kirdaite, G., Uzieliene, I., Denkovskij, J., Bernotas, P., Ivaskiene, T., Mobasheri, A., and Bernotiene, E. (2023). Evaluation of Cartilage Integrity Following Administration of Oral and Intraarticular Nifedipine in a Murine Model of Osteoarthritis. Biomedicines, 11.","DOI":"10.3390\/biomedicines11092443"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13018-014-0138-8","article-title":"Positive side effects of Ca antagonists for osteoarthritic joints-results of an in vivo pilot study","volume":"10","author":"Daniilidis","year":"2015","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Altman, R.D., Manjoo, A., Fierlinger, A., Niazi, F., and Nicholls, M. (2015). The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: A systematic review. BMC Musculoskelet. Disord., 16.","DOI":"10.1186\/s12891-015-0775-z"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/joca.1998.0207","article-title":"The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis","volume":"7","author":"Takahashi","year":"1999","journal-title":"Osteoarthr. Cartil."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/BLO.0b013e31815873f9","article-title":"Hyaluronan suppresses IL-1beta-induced metalloproteinase activity from synovial tissue","volume":"465","author":"Waddell","year":"2007","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jprot.2014.01.016","article-title":"Proteomic analysis of osteoarthritic chondrocyte reveals the hyaluronic acid-regulated proteins involved in chondroprotective effect under oxidative stress","volume":"99","author":"Yu","year":"2014","journal-title":"J. Proteom."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00011-009-0147-y","article-title":"Hyaluronan reversed proteoglycan synthesis inhibited by mechanical stress: Possible involvement of antioxidant effect","volume":"59","author":"Miki","year":"2010","journal-title":"Inflamm. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1093\/rheumatology\/keab020","article-title":"Effect of ultrasound-detected synovitis on therapeutic efficacy of hyaluronic acid injection for symptomatic knee osteoarthritis","volume":"60","author":"Wang","year":"2021","journal-title":"Rheumatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amjms.2019.10.014","article-title":"Differential Expression of Renin-Angiotensin System-related Components in Patients with Rheumatoid Arthritis and Osteoarthritis","volume":"359","author":"Wu","year":"2020","journal-title":"Am. J. Med. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4081\/ejh.2014.2387","article-title":"Expressions of local renin-angiotensin system components in chondrocytes","volume":"58","author":"Tsukamoto","year":"2014","journal-title":"Eur. J. Histochem."},{"key":"ref_40","first-page":"1301","article-title":"The Anti-Inflammatory Potential of ACE2\/Angiotensin-(1-7)\/Mas Receptor Axis: Evidence from Basic and Clinical Research","volume":"18","author":"Rocha","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1007\/s10787-025-01890-z","article-title":"The renin-angiotensin system (RAS) and arthritic diseases: Therapeutic potential for RAS inhibitors","volume":"33","author":"Habib","year":"2025","journal-title":"Inflammopharmacology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-025-07802-4","article-title":"Association of blood pressure with knee pain progression over 4 years in middle-aged and elderly individuals with or at risks for osteoarthritis: Data from the Osteoarthritis Initiative","volume":"45","author":"Fu","year":"2026","journal-title":"Clin. Rheumatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pmn.2021.08.002","article-title":"Association of Hypertension with Knee Pain Severity Among People with Knee Osteoarthritis","volume":"23","author":"Shi","year":"2022","journal-title":"Pain Manag. Nurs."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"112938","DOI":"10.1016\/j.exger.2025.112938","article-title":"Hypertension is associated with knee osteoarthritis pain in an age-dependent manner","volume":"212","author":"Cruz","year":"2025","journal-title":"Exp. Gerontol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40744-023-00625-2","article-title":"Cross-Sectional and Longitudinal Associations of Comorbidities with Knee Symptoms and Radiographic Abnormalities of Osteoarthritis","volume":"11","author":"Li","year":"2024","journal-title":"Rheumatol. Ther."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/1935\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:22:31Z","timestamp":1772616151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/1935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15051935"],"URL":"https:\/\/doi.org\/10.3390\/jcm15051935","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}